Table 2. Correlation of clinical test results of acne rosacea patients and control subjects (Spearman).
| TBUT | Schirmer | TMH | TMD | TMA | |
|---|---|---|---|---|---|
| TMH | |||||
| R2a | 0.391a | 0.390a | — | — | — |
| Pb | 0.000 | 0.000 | — | — | — |
| TMD | |||||
| R2 a | 0.353a | 0.404a | — | — | |
| P | 0.000 | 0.000 | 0.000 | — | — |
| TMA | |||||
| R2a | 0.0.368a | 0.0.394a | 0.0.934a | 0.910a | — |
| P | 0.000 | 0.000 | 0.000 | 0.000 | — |
| OSDI | |||||
| R2 | 0.267a | 0.312a | 0.589a | 0.527a | 0.613a |
| P | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
Abbreviations: p, significance of correlation; r, Spearman's correlation coefficient; TBUT, tear film break-up time; TMA, tear meniscus cross-sectional area; TMD, tear meniscus depth; TMH, tear meniscus height.
a
Significance at the 0.001 level.
b
Significance at the 0.05 level.